PL430531A1 - Podłoże oraz kompozycja farmaceutyczna je zawierająca - Google Patents

Podłoże oraz kompozycja farmaceutyczna je zawierająca

Info

Publication number
PL430531A1
PL430531A1 PL430531A PL43053119A PL430531A1 PL 430531 A1 PL430531 A1 PL 430531A1 PL 430531 A PL430531 A PL 430531A PL 43053119 A PL43053119 A PL 43053119A PL 430531 A1 PL430531 A1 PL 430531A1
Authority
PL
Poland
Prior art keywords
weight
drug
group
fatty acids
pharmaceutical
Prior art date
Application number
PL430531A
Other languages
English (en)
Other versions
PL245545B1 (pl
Inventor
Paweł BIERNAT
Jan MELER
Konrad Krajewski
Dawid BURSY
Original Assignee
Biotts Spółka Akcyjna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotts Spółka Akcyjna filed Critical Biotts Spółka Akcyjna
Priority to PL430531A priority Critical patent/PL245545B1/pl
Priority to US16/963,532 priority patent/US12201621B2/en
Priority to EP20837275.5A priority patent/EP3996677A4/en
Priority to PCT/PL2020/050050 priority patent/WO2021006753A1/en
Publication of PL430531A1 publication Critical patent/PL430531A1/pl
Publication of PL245545B1 publication Critical patent/PL245545B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/925—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of animal origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Przedmiotem zgłoszenia jest podłoże farmaceutyczne dla znieczulających substancji czynnych charakteryzujące się tym, że zawiera silnie solwatujący rozpuszczalnik aprotyczny z grupy sulfotlenków w ilości od 0,25% do 15% masy leku, amid kwasu węglowego w ilości od 1% do 5% masy leku, oraz tłuszcz zwierzęcy o zawartości nienasyconych kwasów tłuszczowych do około 55%, organiczny związek chemiczny z grupy alkoholi dwuhydroksylowych od 5% do 15% masy leku, organiczny związek chemiczny z grupy alkoholi alifatycznych od 0,05% do 1,5% masy leku, organiczny związek chemiczny z grupy jednonienasyconych kwasów tłuszczowych typu omega-9 od 2% do 10% masy leku. Zgłoszenie obejmuje też kompozycję farmaceutyczną, charakteryzującą się tym, że zawiera powyższe podłoże oraz substancje czynne, przy czym stosunek wagowy substancji pomocniczych bezwodne, farmaceutyczne podłoże maściowe do smalcu wieprzowego wynosi od 1:2 do 2:1 a proporcja wagowa mieszaniny alkoholu izopropylowego i glikolu wynosi od 1:5 do 1:15 i zawiera dimetylosulfotlenek w zakresie od 0,25% do 15% masy kompozycji.
PL430531A 2019-07-09 2019-07-09 Kompozycja farmaceutyczna w postaci maści zawierająca substancję znieczulającą PL245545B1 (pl)

Priority Applications (4)

Application Number Priority Date Filing Date Title
PL430531A PL245545B1 (pl) 2019-07-09 2019-07-09 Kompozycja farmaceutyczna w postaci maści zawierająca substancję znieczulającą
US16/963,532 US12201621B2 (en) 2019-07-09 2020-07-09 Base and pharmaceutical composition containing it
EP20837275.5A EP3996677A4 (en) 2019-07-09 2020-07-09 BASE AND PHARMACEUTICAL COMPOSITION CONTAINING IT
PCT/PL2020/050050 WO2021006753A1 (en) 2019-07-09 2020-07-09 A base and a pharmaceutical composition containing it

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL430531A PL245545B1 (pl) 2019-07-09 2019-07-09 Kompozycja farmaceutyczna w postaci maści zawierająca substancję znieczulającą

Publications (2)

Publication Number Publication Date
PL430531A1 true PL430531A1 (pl) 2021-01-11
PL245545B1 PL245545B1 (pl) 2024-08-26

Family

ID=74114727

Family Applications (1)

Application Number Title Priority Date Filing Date
PL430531A PL245545B1 (pl) 2019-07-09 2019-07-09 Kompozycja farmaceutyczna w postaci maści zawierająca substancję znieczulającą

Country Status (4)

Country Link
US (1) US12201621B2 (pl)
EP (1) EP3996677A4 (pl)
PL (1) PL245545B1 (pl)
WO (1) WO2021006753A1 (pl)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB315306A (en) * 1928-07-11 1930-05-08 Chem Fab Vormals Sandoz Improvements in the preparation of anti-inflammatory and soothing ointments
US4265883A (en) 1979-10-01 1981-05-05 Cameron Mable R Composition and process for treating uterine prolapse
DE3811461A1 (de) 1987-04-23 1988-11-03 Christina Rada Koerperbehandlungsmittel zur pflege der koerperhaut
CN1084068A (zh) 1992-09-12 1994-03-23 王振永 烧烫创伤软膏的制作方法
US5814659A (en) * 1996-04-23 1998-09-29 Dtr Dermal Therapy (Barbados) Inc. Topical analgesic composition
JPH1112177A (ja) * 1997-06-25 1999-01-19 Teikoku Seiyaku Co Ltd 安定なアスピリン含有外用製剤
US6673363B2 (en) * 1999-12-16 2004-01-06 Dermatrends, Inc. Transdermal and topical administration of local anesthetic agents using basic enhancers
US6638981B2 (en) * 2001-08-17 2003-10-28 Epicept Corporation Topical compositions and methods for treating pain
ES2223277B1 (es) * 2003-06-19 2006-03-01 Fernando Bouffard Fita Composicion anestesica para administracion topica.
UA83402C2 (en) 2006-07-06 2008-07-10 Светлана Владимировна Бабий Anti-inflammatory analgesic ointment

Also Published As

Publication number Publication date
EP3996677A1 (en) 2022-05-18
US12201621B2 (en) 2025-01-21
US20210401817A1 (en) 2021-12-30
EP3996677A4 (en) 2023-08-02
PL245545B1 (pl) 2024-08-26
WO2021006753A1 (en) 2021-01-14

Similar Documents

Publication Publication Date Title
RU2621615C2 (ru) Фармацевтическая композиция, содержащая луликоназол
US6077867A (en) Pig appeasing pheromones to decrease stress, anxiety and aggressiveness
ES2625268T3 (es) Composición farmacéutica que comprende un derivado de amida que inhibe el crecimiento de las células cancerosas y un lubricante de una sal no metálica
KR101651448B1 (ko) 체지방을 국소적으로 증가시키는 방법 및 조성물
DE69833684D1 (de) Antioxidierende stabilisierungssysteme für pharmazeutische formulierungen
US10568890B2 (en) Lactate-based fulvestrant or fulvestrant derivative oily preparation and preparation method thereof
RU2715103C2 (ru) Местная композиция и носитель для введения фармацевтически или косметически активных ингредиентов
EP2470172A1 (en) Pharmaceutical formulations and methods of use
RU2009127500A (ru) Фармацевтические композиции и способ лечения воспаления у крупного рогатого скота и других животных
RU2017111503A (ru) КОМПОЗИЦИИ(17-β)-3-ОКСОАНДРОСТ-4-ЕН-17-ИЛ УНДЕКАНОАТА И СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ
JP5906304B2 (ja) 環状デプシペプチドを含む懸濁液型局所製剤
TW201919584A (zh) 用於動物寄生蟲之防治及預防的可局部投予之調配物
JP2024544415A5 (pl)
WO2012140504A1 (en) Therapeutic compounds
JP6742487B1 (ja) エルデカルシトール含有医薬組成物
CN102481249A (zh) 包含相对构型-n-[6-[(2r，6s)-2，6-二甲基-4-吗啉基]-3-吡啶基]-2-甲基-4’-(三氟甲氧基)-[1，1’-联苯]-3-甲酰胺的局部药物组合物
US20190241498A1 (en) Resveratrol esters
EP2982369A1 (en) Preparation for treating equine inflammation
CN103417478A (zh) 一种以水为基质的伊维菌素o/w型注射液及其制备方法
US20170369465A1 (en) Soothing pro-pheromonal composition for mammals
TR200302027T4 (tr) Hayvanlarda görülen parazit kaynaklı hastalıkarın tedavisine yönelik ilaç kompozisyonları
JP2008522997A (ja) 酸によるグルココルチコイドエステルの安定化
PL428534A1 (pl) Nośnik farmaceutyczny dla substancji czynnych oraz kompozycja farmaceutyczna ją zawierająca
US20180147138A1 (en) Transdermal liquid preparation
EP4114358A1 (en) Topical pharmaceutical formulations of a cyclic depsipeptide